Suppr超能文献

关于在给予碘造影剂和钆基造影剂前使用预处理药物的调查。

A survey on the use of premedication prior to iodinated and gadolinium-based contrast material administration.

机构信息

Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan 48109-5030, USA.

出版信息

J Am Coll Radiol. 2011 May;8(5):345-54. doi: 10.1016/j.jacr.2010.09.001.

Abstract

PURPOSE

The aim of this study was to assess Society of Uroradiology member use of premedication before the intravenous administration of low-osmolality iodinated contrast materials (LOCM) and gadolinium-based contrast materials (GBCM).

METHODS

Society of Uroradiology members were invited to complete a Web-based survey concerning the use of premedication. The survey included scenarios concerning intravenous LOCM or GBCM injection in which respondents were asked whether they would recommend premedication or withhold contrast material injection. Results for LOCM questions were compared with those for GBCM questions. Question responses for LOCM were also compared with those from a similar Society of Uroradiology survey published in 1995.

RESULTS

Sixty-two of 72 respondents (86%) used standardized premedication regimens. Fifty-nine of 61 described regimens (97%) included oral corticosteroids and 48 (79%) antihistamines. Twenty of 69 respondents (29%) had separate urgent premedication regimens. There was general agreement concerning premedication use; however, responses were inconsistent in patients with severe food or medication allergies, severe symptomatic asthma, or prior mild urticarial reactions. More respondents recommended premedication before LOCM than GBCM administration. More respondents recommended premedication or avoidance of contrast material injection in patients with prior contrast reactions in the current study compared with the 1995 study.

CONCLUSIONS

There is frequent agreement among uroradiologists concerning the use of corticosteroid prophylaxis, but there is inconsistency in some clinical situations. The threshold for premedication is often lower for LOCM than GBCM. Since 1995, recommendations for use of premedication have become more widespread.

摘要

目的

本研究旨在评估泌尿放射学会会员在静脉注射低渗碘对比剂(LOCM)和钆基对比剂(GBCM)前使用预用药的情况。

方法

邀请泌尿放射学会会员填写一份关于预用药使用情况的网络调查。调查包括静脉注射 LOCM 或 GBCM 时的情况,受访者被问及是否建议预用药或暂停注射对比剂。将 LOCM 问题的结果与 GBCM 问题的结果进行比较。还将 LOCM 问题的答案与 1995 年发表的类似泌尿放射学会调查的答案进行比较。

结果

在 72 名受访者中,有 62 名(86%)使用了标准化的预用药方案。在 61 名描述方案的受访者中,有 59 名(97%)包括口服皮质类固醇,有 48 名(79%)包括抗组胺药。在 69 名受访者中,有 20 名(29%)有单独的紧急预用药方案。尽管在严重食物或药物过敏、严重症状性哮喘或先前轻度荨麻疹反应的患者中,预用药的使用存在不一致的情况,但总体上还是存在共识。与 GBCM 给药相比,更多的受访者建议在 LOCM 给药前使用预用药。与 1995 年的研究相比,在当前研究中,更多的受访者建议在有先前对比剂反应的患者中使用预用药或避免使用对比剂。

结论

在使用皮质类固醇预防方面,泌尿科医生之间经常达成一致,但在某些临床情况下存在不一致。LOCM 的预用药阈值通常低于 GBCM。自 1995 年以来,建议使用预用药的范围越来越广。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验